🇰🇷 Slentrol in South Korea

Slentrol (DIRLOTAPIDE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Slentrol in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in South Korea

Frequently asked questions

Is Slentrol approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Slentrol in South Korea?

Marketing authorisation holder not available in our data.